NanoVation-GS
RPM and early exacerbations alert for optimal management of respiratory patients
Company Overview
Snapshot
Founded in March 2014 by Gregory Shuster, Hossam Haick, and Nadav Bachar, NanoVation-GS operates with 1–10 employees. The company has secured $8.76M across 7 funding rounds from 3 investors. In July 2021, NanoVation-GS received $5.9 million from the European Innovation Council Fund for its respiratory monitoring device.
Business overview
NanoVation-GS is a med-tech startup focused on alleviating the suffering and reducing the financial burden associated with frequent hospitalizations for chronic respiratory patients, including those with COPD and asthma. The company's core product, SenseGuard™, is a non-invasive, patient-friendly device designed for monitoring respiratory conditions. It measures unique lung function biomarkers from effortless tidal breathing, enabling early detection and treatment of exacerbations before they become acute. NanoVation-GS operates within the Health Tech & Life Sciences sector, specifically targeting medical devices, digital healthcare, and patient remote monitoring markets.
Strategic signal
In July 2021, NanoVation-GS secured a significant $5.9 million from the European Innovation Council Fund for its respiratory monitoring device. This substantial grant validates the potential of SenseGuard™ to address critical needs in chronic respiratory care, signaling strong institutional confidence in the company's technology and its ability to impact patient outcomes and healthcare costs.
Log in to access full profile ›Company Intelligence Q&A
- What is NanoVation-GS's primary focus?
- NanoVation-GS is a med-tech startup dedicated to improving the management of chronic respiratory patients, such as those with COPD and asthma, by reducing hospitalizations and associated costs.
- What is SenseGuard™?
- SenseGuard™ is a device developed by NanoVation-GS that monitors patients' respiratory conditions by measuring lung function biomarkers from effortless breathing, enabling early detection and treatment of exacerbations.
- When was NanoVation-GS founded and by whom?
- NanoVation-GS was founded in March 2014 by Gregory Shuster, Hossam Haick, and Nadav Bachar.
- What significant funding did NanoVation-GS receive in 2021?
- In July 2021, NanoVation-GS received $5.9 million from the European Innovation Council Fund for its respiratory monitoring device.
- What was a key grant received by NanoVation-GS in 2020?
- In July 2020, NanoVation-GS received a grant from EU Horizon 2020 for its respiratory monitoring device.